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Spontaneous curvatureMany amphiphilic antimicrobial peptides permeabilize bacterial membranes via successive steps of binding, re-
alignment and/or oligomerization. Here, we have systematically compared the lipid interactions of two structurally
unrelated peptides: the cyclicβ-pleated gramicidin S (GS), and theα-helical PGLa. 19F NMRwas used to screen their
molecular alignment in variousmodelmembranes over awide range of temperatures. Both peptideswere found to
respond to the phase state and composition of these different samples in a similar way. In phosphatidylcholines,
both peptides ﬁrst bind to the bilayer surface. Above a certain threshold concentration they can re-align and im-
merse more deeply into the hydrophobic core, which presumably involves oligomerization. Re-alignment is most
favorable around the lipid chainmelting temperature, and also promoted by decreasing bilayer thickness. The pres-
ence of anionic lipids has no inﬂuence in ﬂuidmembranes, but in the gel phase the alignment states aremore com-
plex. Unsaturated acyl chains and other lipidswith intrinsic negative curvature prevent re-alignment, hence GS and
PGLa do not insert into mixtures resembling bacterial membranes, nor into bacterial lipid extracts. Cholesterol,
which is present in high concentrations in animal membranes, even leads to an expulsion of the peptides from
the bilayer and prevents their binding altogether. However, a very low cholesterol content of 10%was found to pro-
mote binding and re-alignment of both peptides. Overall, these ﬁndings show that the ability of amphiphilic pep-
tides to re-align and immerse into a membrane is determined by the physico-chemical properties of the lipids,
such as spontaneous curvature. This idea is reinforced by the remarkably similar behavior observed here for two
structurally unrelated molecules (with different conformation, size, shape, charge), which further suggests that
their activity at the membrane level is largely governed by the properties of the constituent lipids, while the selec-
tivity towards different cell types is additionally ruled by electrostatic attraction between peptide and cell surface.
This article is part of a Special Issue entitled: Interfacially Active Peptides and Proteins. Guest Editors: William C.
Wimley and Kalina Hristova.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
All multicellular organisms rely on antimicrobial peptides (AMPs) as
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problem of acquired antibiotic resistance. Since activity was found to
occur in a non-sterospeciﬁc manner, it was concluded that these
peptides physically permeabilize and/or penetrate the lipid envelope
of the bacteria [10–13]. To rationalize their molecular mechanisms
in terms of peptide–lipid interactions, let us consider the relevant
parameters which determine the equilibria of (i) peptide binding to
the membrane surface, (ii) re-alignment and deeper immersion into
the bilayer, and ﬁnally (iii) membrane rupture. These successive steps
are obviously inﬂuenced by both, the type of peptide as well as the
lipid composition. It is well recognized that anionic bacterial mem-
branes have a high electrostatic afﬁnity for cationic AMPs (step i),
whereas uncharged eukaryoticmembraneswith a high cholesterol con-
tent are more resilient to antimicrobial attack (steps ii and iii) [13–16].
Here, we will demonstrate for two completely unrelated AMPs that the
second step (ii) of re-alignment and bilayer immersion is consistently
and quantitatively governed by the lipids, independent of peptide
sequence, secondary structure or charge. The only relevant parameter
to be considered here for each individual peptide is the actual threshold
concentration at which it will start to re-align. When studying the
systemunder conditions close to this threshold,wewill see that the equi-
librium gets shifted by the different lipid environments in a consistent
manner, irrespective of the peptide itself.
The well-known concept of Shai–Matsuzaki–Huang describes how
amphiphilic peptides bind to and immerse into a lipid bilayer, thereby
disrupting its integrity [17–19]. Permanent or transient self-assembly
of the peptides can lead to a transmembrane pore, e.g. a “barrel-stave”
or “toroidal wormhole”, and non-speciﬁc bilayer rupture can occur
e.g. via a “carpet”mechanism. From a structural point of view, these sit-
uations can be described in terms of rigid bodies (unless unfolding and/
or aggregation events have to be considered) [20–22]. The amphiphilic
molecules are simply characterized by their alignment in themembrane,
and by their mobility and oligomeric state. Solid state NMR in macro-
scopically aligned samples has been established as a routine method to
characterize such peptides carrying selective isotope labels (2H, 13C,
15N, 19F) [23–30]. 31P NMR is conveniently used to monitor the state of
the lipids [23,31,32]. Numerous AMPs have thus been studied in
model membranes of varying composition [29,30,33–35]. However, it
is very difﬁcult to compare these data with one another, because
the exact sample conditions are known to have a dramatic impact
on peptide behavior. In a comprehensive series of experiments it
has been systematically described how the representative antimi-
crobial peptide PGLa changes its membrane alignment, dynamics
and oligomerization state, not only as a function of concentration,
but also as a function of lipid composition, temperature, sample
hydration, pH, and in the presence of other peptides [27,36–43].
Furthermore, a recent study has shown that re-alignment of the
related peptide MSI-103 is governed by the spontaneous membrane
curvature [44].
To elucidate the fundamental role of physico-chemical lipid proper-
ties and membrane composition, it is essential to study different AMPs
under identical conditions, based on the same sample preparation
protocol and experimental set-up. Here, we have systematically charac-
terized and compared two structurally unrelated AMPs in various lipid
environments in a parallel manner. Two aspects are of particular
novelty: (i) a single ﬂuorine-label was used as a 19F NMR reporter
group to probe the orientation and re-alignment of the GS and PGLa,
as the complete structures and alignment states are already known for
both peptides from previous reports [36,37,41,27,45,46]; (ii) instead
of focusing only on a single temperature, themethod is sensitive enough
to run extensive temperature series encompassing both the gel state
and the ﬂuid liquid crystalline phases of the different membrane sys-
tems. Even though this rapid screening approach is based on spectra
with relatively low quality, the present solid state 19F NMR study adds
two further supportive examples to our recent concept of lipid–protein
interactions. In a systematic analysis of the related α-helical peptideMSI-103, we had demonstrated for a wide range of different lipids that
peptide re-alignment and membrane insertion are governed simply by
the spontaneous curvature of the lipid bilayer [44].
PGLa (GMASKAGAIAGKIAKVALKAL-NH2) is a member of the
magainin family of antimicrobial peptides, isolated from the skin of the
African clawed frog Xenopus laevis [47]. It is unstructured in solution,
but folds into an amphiphilic α-helix upon binding to a lipid bilayer,
with a net charge of +5. In DMPC and in the presence of negatively
charged DMPG, the cationic peptide was shown to re-align in a
concentration-dependent manner from a surface-bound “S-state” to an
obliquely tilted “T-state” [36–38]. The latter state has been attributed
to antiparallel homodimers, which are more deeply immersed in
the hydrophobic bilayer core [48,49]. When the membrane is cooled
down to the gel phase, PGLa can re-align even further into a
completely inserted “I-state”, which presumably corresponds to an
oligomeric transmembrane pore [41]. In the presence of its synergis-
tic partner peptide Magainin 2, this stable I-state has been observed
for PGLa even in the ﬂuid liquid crystalline phase of DMPC/DMPG
[39,42,43]. In the following, we will refer to both the T-state and
the I-state of PGLa as “re-aligned”, to be differentiated from the orig-
inal surface-bound S-state.
The second peptide investigated here is gramicidin S (GS, cyclo[Pro-
Val-Orn-Leu-DPhe]2; Orn: ornithine, DPhe: (D)-phenylalanine) from
Aneurinibacillus migulanus (formerly known as Bacillus brevis) [50],
which represents one of the few AMPs already in use as an antibiotic
drug [51,52]. This cationic decapeptide has a symmetric cyclic β-pleated
structure with an amphiphilic character and a net charge of +2. In
DMPC/DMPG membranes, GS ﬁrst binds to the membrane surface, but
it can re-align and ﬂip into the hydrophobic core as a function of con-
centration and temperature. The membrane-inserted state has been
suggested to form a transmembrane pore, consisting of an oligomeric
β-barrel [27,45,46]. The structures and re-alignment transitions of
both, PGLa and GS, have been comprehensively characterized by solid
state 19F NMR in macroscopically oriented membrane samples [27–30,
35–42,45,46,53–55], and 2H NMR was used to justify the viability
of the 19F-labeling strategy [56]. In these previous investigations, the
non-natural amino acids CF3-phenylglycine (CF3-Phg), 4F-phenylglycine
(4F-Phg), or CF3-bicyclopentylglycine (CF3-Bpg), were used as 19F NMR
reporters. In PGLa, a single 19F-labeled amino acid had been substituted
one-by-one for positions Ile9, Ala10, Ile13, or Ala14. In gramicidin
S, either the pair of Leu or of Val residues had been double-labeled.
These selective substitutions affected neither the structure nor the
antimicrobial activity of the peptide analogues [27,28,45,46,54,55].
This way, the structures and re-alignment behavior of membrane-
bound PGLa and GS have been described from a combination of
several individual NMR labels in previous works. On this basis, it is
now possible to select a single 19F-labeled position on each peptide
to serve as a ﬁngerprint for identifying the different alignment states
that are functionally relevant. Namely, for PGLa the CF3-Phg label in
position of Ile13 is ideally suited to discriminate between the
surface-bound and the re-aligned states [41,53,57]. In the case of
GS, the 19F NMR signal of 4F-Phg in place of Leu is a characteristic
marker to observe re-alignment [27,29,30,45,46].
Here, we have monitored and compared the re-alignment of the
selected 19F-labeled analogues of PGLa and GS in several different
types of model membranes. This way, it should be possible to correlate
their structural behavior with the role of lipid composition and other
parameters under equivalent conditions. These new data thus extend
our previous analyses of PGLa andGS, which had been carried outmain-
ly as a function of concentration and temperature in DMPC and DMPC/
DMPG [36,37,41,45,46]. Now, the peptides are systematically examined
and compared further in (i) other saturated lipids with varying acyl
chain length, (ii) bilayers with unsaturated acyl chains, (iii) bilayers
with varying content of anionic head groups, (iv) bilayers with varying
amounts of cholesterol, and (v) lipid mixtures with typical bacterial
lipid compositions.
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2.1. Peptide synthesis and puriﬁcation
All peptides were synthesized using Fmoc-strategy according
to published procedures [54,28,58]. In PGla, Ile13 was substituted with
L-4-CF3-phenylglycine to give Gly-Met-Ala-Ser-Lys-Ala-Gly-Ala-Ile-Ala-
Gly-Lys-(CF3-Phg)-Ala-Lys-Val-Ala-Leu-Lys-Ala-Leu-NH2. For GS, 4F-
phenylglycine was used as a 19F-label in place of Leu, thus yielding the
analogue cyclo[Pro-Val-Orn-(4F-Phg)-DPhe]2. Starting off with the race-
mic (D/L) CF3-Phg amino acid, the respective peptide diastereomers
were puriﬁed by RP-HPLC on Grace Vydac C18 columns (10 × 250 mm)
using individually adjusted linear H2O/acetonitrile gradients. The mobile
phase contained 5mMHCl instead of TFA to ensure a 19F-free background
for NMR [54]. Analytical RP-HPLC (Grace Vydac C18: 4.6 × 250 mm
column) and MALDI-TOF (Biﬂex III, Bruker) were used to identify the
peptides and characterize their purity [54,58].2.2. NMR sample preparation
The lipids DLPC, DPPC, DOPC, DMPC, DMPG, DMPS, DMPE, POPE,
and total E. coli lipid extract (TLE) were obtained from Avanti Polar
Lipids, cholesterol was from Sigma-Aldrich. Appropriate amounts of
peptides and lipids were separately weighed out as dry powders,
using a Mettler-Toledo microbalance. Next, stock solutions were pre-
pared in a MeOH/CHCl3 solvent mixture (about 2:1). The aliquots
were combined to achieve the desired peptide-to-lipid ratio in a single
vessel for each sample. These mixed solutions were used to prepare
macroscopically oriented lipid bilayers on glass supports and hydratedFig. 1.Characteristic solid state 19FNMRﬁngerprint spectra of 19F-labeled PGLa (left,withCF3-Phg i
bilayers. Themolecular structures of the two amphiphilic peptides and their respective alignments
(top) and the re-aligned states (bottom). Arrows indicate the 19F dipolar coupling of PGLa (only o
frequency δiso (dotted line). The spectral intensity in these regions serves as a ﬁngerprint to ide
signature in the surface-bound state, while it shows upﬁeld signals upon re-alignment. GS has a
downﬁeld edge of the spectrum. As outlined below, these peptides can reversibly change their alvia water vapor of 96% relative humidity, as previously described [36,
37,45,46].
2.3. Solid state 19F and 31P NMR
All spectra were acquired on 500 MHz Unity (Varian) or Avance
III (Bruker) spectrometers at 202.5 MHz (31P) and 472 MHz (19F). Ei-
ther aHahn-Echo (31P, and 19F chemical shift anisotropy inGS) or a single
90° pulse (19F dipolar coupling in PGLa)were appliedwith 1H-decoupling
(for 19F-observation) as described earlier [36,37,45,46,54]. Carewas taken
to prevent dehydration of the samples (as monitored by 31P NMR) by
wrapping them in plastic ﬁlm and, if necessary, re-hydration and re-
measuring [41,53]. Temperature control units from Varian/Bruker were
used, and the respective probeheads were carefully calibrated externally
using the 1H NMR thermometer [59]. Temperature-dependent measure-
ments were performed by scanning upwards from at least 10° below the
lipid phase transition temperature Tm to at least 10° above Tm in steps of
5°. Samples, placed such that their membrane normal is parallel to
B0(horizontal membrane), were equilibrated for at least 10 min at each
temperature (typically for 30 min). The 19F NMR spectra were externally
referenced using an aqueous solution of 100 mM NaF, the resonance of
which was set to−119.5 ppm at 35 °C [60], and for 31P NMR calibration
with the primary reference of 85% H3PO4 was used.
3. Results
3.1. Characteristic alignment states of PGLa and GS in DMPC
Fig. 1 illustrates some representative 19F NMR spectra from our previ-
ous studies of PGLa and GS, which are used here to distinguish thenplace of Ile13) andGS (right,with4F-Phg in place of Leu), inmacroscopically orientedDMPC
in a horizontal membrane are illustrated besides each spectrum, i.e. the surface-bound states
ne splitting indicated within the triplet), and the chemical shift of GS relative to the isotropic
ntify the alignment state of each peptide. We note that PGLa has a characteristic downﬁeld
near-isotropic signal in the surface-bound state, and re-alignment produces intensity at the
ignment states as a function of concentration, temperature, and lipid composition.
Fig. 2. (A) Concentration-dependent re-alignment of PGLa (left) andGS (right), asmonitored
by 19F NMR in oriented DMPC bilayers at 25 °C (1 mg lipid per glass slide, hydration at 96%
relative humidity). The peptide-to-lipid molar ratio is indicated as P/L. (B) Re-alignment of
PGLa (left, P/L = 1:50) and GS (right, P/L = 1:40) in DMPC, monitored as a function of
temperature. The isotropic position is drawn as a dotted line in the spectra. The lipid acyl
chain melting temperature is indicated by the arrow heads on the temperature scale.
1 In this context it is important to note that the spectra in Fig. 2Awere acquired at 25 °C,
i.e. relatively close to the lipid chain melting transition of DMPC at Tm ~23 °C, because in
this region the re-alignment equilibrium is most pronounced and can be shifted by rela-
tively weak effects.
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distinctly different lineshapes in their two functionally relevant states.
More detailed information on the interpretation of these data can be
found in previous publications [27,36,37,41,45,46]. Here, we just give a
brief description of the spectral features and their meaning. For PGLa,
the 19F dipolar coupling of the selected “ﬁngerprint” CF3-label gives a
positive +5.7 kHz splitting in the surface-bound state, which changes
to a negative value upon re-alignment (−2.9 Hz in the tilted T-state,
and −4.0 Hz in the inserted I-state [41]). It is the sign that matters
here, and it can be read out by simple inspection of the PGLa spectra.
Downﬁeld signals, to the left of the isotropic frequency δiso (indicated
as a dotted line) have a positive splitting and represent the S-state,
while upﬁeld signals to the right of δiso have a negative splitting and rep-
resent a re-aligned state of PGLa [36,37]. In gramicidin S, the chemical
shift of the “ﬁngerprint” 19F-labels changes from a narrow peak near
δiso in the surface-bound state (−118 ppm), to a broad downﬁeld signal
upon re-alignment (−70 to−80 ppm, near the edge of the powder pat-
tern) [27,45,46]. The convenient aspect in the choice of these ﬁngerprint
signals is that for both, PGLa and GS, the 19F NMR signals move far across
the spectral width, and they can be readily assessed relative to the well-
deﬁned isotropic frequency δiso.
While both peptides aremonomeric in the surface-bound state, their
re-alignment and membrane immersion have been suggested to be
accompanied by self-assembly, yielding a dimer in the case of PGLa
[37,48], and a β-barrel for GS [46]. We also infer for both peptides that
they penetrate more deeply into the hydrophobic bilayer core upon
re-alignment, which is supposedly themost critical step towardsmem-
brane permeabilization [37,41]. From the corresponding 31P NMR
analyses of the lipid matrix, it is known that the bilayers remain
lamellar and well oriented. Also in this work (31P NMR data not
shown), non-lamellar isotropic or hexagonal lipid signals were
generally absent (except for some cubic morphologies observed in
the bacterial total lipid extract preparations). Under the conditions
used in this study, neither PGLa nor GS can thus induce the forma-
tion of micelles or non-bilayer phases in themacroscopically orient-
ed and well hydrated membranes.
3.2. Peptide re-alignment as a function of concentration and temperature
For a systematic investigation,we ﬁrst have to select a suitable range
of peptide concentrations and temperatures, at which the functionally
relevant re-alignment of PGLa and GS can be observed. We therefore
repeated and reproduced the previously published concentration series
for both peptides inDMPCunder uniform conditions of sample prepara-
tion and experimental set-up [27,37,53]. Samples were prepared with
peptide-to-lipid (P/L) molar ratios of 1:20, 1:35, 1:50, 1:80, 1:100,
1:150, 1:200, and 1:400 for PGLa, and 1:20, 1:40, 1:80 and 1:200
for GS. From these series, a representative set of 19F NMR spectra (all
measured at 25 °C) has been selected for illustration in Fig. 2A. Both
peptides are seen to be surface-bound at low concentration (downﬁeld
signals for PGLa, and near-isotropic signal for GS) up to a certain thresh-
old, above which the re-alignment starts to occur (upﬁeld signals for
PGLa, and downﬁeld signal for GS). The re-alignment of PGLa involves
an equilibrium between the two discrete states [39], and fast
exchange gives rise to a time-averaged signal at the isotropic position
(around P/L≈ 1:100) [37]. The immersed state is reached at P/L≈ 1:50
for PGLa in DMPC. In the case of GS, the two states give rise to discrete
signals, and the exchange seems to be slower. Hence, starting with the
surface-bound state (signal near the isotropic position), an additional
(downﬁeld) signal corresponding to the re-aligned state starts to grow
with increasing peptide concentration up to P/L≈ 1:40. A certain fraction
of the peptide is seen to remain in the surface-bound state even at higher
concentrations. The behavior of both systems in Fig. 2A can thus be
interpreted in terms of a concentration-dependent transition from a
surface-bound state to a re-aligned state with increasing P/L ratio. PGLa
is in fast exchange on the millisecond time scale of the dipolar coupling,while GS is in slow exchange. Re-alignment is complete at about 1:50
for PGLa and 1:40 for GS [40,46]. From these data we can identify the ap-
propriate conditions for all further experiments, i.e.when each system is
most sensitive to any factors that may affect the re-alignment equilibri-
um.1 We thus selected the P/L ratios at which each peptide has just
reached its re-aligned state in DMPC at 25 °C, namely at 1:50 for PGLa
and 1:40 for GS. In all further experiments, these particular P/L ratios
will be used to examine and compare the re-alignment behavior of the
two peptides.
Next, we monitored the effect of the lipid phase state, by running
heating scans over a broad range of temperatures around the acyl
chain melting transition Tm (23 °C). 19F NMR spectra were acquired in
DMPC from 15 °C to 55 °C, as shown in Fig. 2B. In both systems we
can discern three different temperature regimes that determine the
alignment of the peptides: (i) well above the lipid phase transition,
(ii) around and slightly above Tm, and (iii) well below Tm. For the sake
of argument, we will discuss the classical “ﬂuid” (liquid disordered)
conditions ﬁrst, before noting any observations in the biologically less
relevant gel-phase. In the case of PGLa, the peptide is preferentially
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high temperatures (45–55 °C). Upon cooling, successive re-alignment
occurs through fast exchange (isotropic signal at 35 °C, just like P/L =
1:100 in Fig. 2A) reaching the fully tilted state around Tm (upﬁeld
signals). Below the lipid phase transition, PGLa remains in the tilted
state [46]. In a similar way, GS prefers a surface-bound state at high
temperatures (near-isotropic signal), while re-alignment into the
membrane-immersed state is most pronounced around Tm (downﬁeld
signals). In the lipid gel phase, on the other hand, GS produces a broad
powder-like lineshape that indicates a lack of alignment, so the two pep-
tides differ in this particular aspect. Nevertheless, wemay altogether con-
clude that PGLa and GS behave similarly in many ways, as they (i) prefer
their surface-bound state at high temperature, yet (ii) they can favorably
re-align and get immersed into the membrane, which (iii) occurs most
prominently in a temperature range just above and around the lipid
phase transition. For all further experiments, we will thus not only
prepare samples with the selected P/L ratio, but we will also acquire all
NMR data as temperature-dependent series by stepping up in intervals
of 5° from±10° below to above Tm of the respective lipid.
3.3. Inﬂuence of lipid acyl chain length
Saturated phosphatidylcholines are conveniently used to study the
impact of bilayer thickness on peptide–lipid interactions. In the series
DLPC (di-C12:0) → DMPC (di-C14:0) → DPPC (di-C16:0) the acyl
chain length successively increases by twomethylene units, and the re-
spective Tm values (−1 °C, 23 °C, 41 °C) [61] are within an experimen-
tally accessible range. All of these samples with PGLa and GS gave well-
oriented lamellar 31P NMR spectra (data not shown). Fig. 3 shows that
PGLa has a pronounced preference to re-align in thin DLPC bilayers.Fig. 3. Inﬂuence of bilayer thickness on the re-alignment of PGLa (left, P/L = 1:50) and GS
(right, P/L = 1:40) in saturated phosphatidylcholines with different acyl chain lengths,
measured as a function of temperature. The phase transition temperatures of DLPC
(Tm ~ −1 °C) (A), DMPC (Tm ~ 23 °C) (B) and DPPC (Tm ~ 41 °C) (C) are indicated
by arrowheads.Only upﬁeld signals are observed here for the full temperature window
scanned over Tm±10°. In DMPC, the temperature series corresponds to
an excerpt from Fig. 2B, showing successive re-alignment from surface-
bound tomembrane-immersedwith decreasing temperature. Note that
fast exchange between the two states of PGLa (time-averaged signal at
δiso) is seen here at the highest temperature of Tm+10 °C. In thickDPPC
bilayers, ﬁnally, this fast exchange is more pronounced and maintained
towards lower temperatures, and full re-alignment is not achieved even
at Tm−10 °C. For GS, the same trend is seen as for PGLa, namely that re-
alignment occurs most favorably in thin DLPC, and is least favorable in
DPPC. In fact, the membrane-inserted state of GS is stabilized in DLPC
over a very extended temperature range of about 30° aroundTm (full se-
ries not shown). In DMPC, GS becomes re-aligned over a modest tem-
perature window of about 15° just above Tm, while in DPPC it does
not re-align signiﬁcantly and remains surface-bound over the entire
temperature window. Wemay thus conclude that the two peptides be-
have similarly with regard to their orientational preferences, because
they re-align much more favorably in thin bilayers as compared to
thick ones.
3.4. Inﬂuence of negatively charged lipids
The outer monolayer of eukaryotic plasma membranes contains
mostly zwitterionic lipids with choline head groups, which are readily
mimicked by phosphocholine model membranes, such as DMPC used
here. Bacterialmembranes, however, are enriched in negatively charged
lipids and attract cationic AMPs electrostatically. PGLa is known to
require some anionic lipids in order to bind to vesicles in dilute suspen-
sions [38,62]. Nevertheless, when using macroscopically oriented
samples, the peptide has been shown to be fully retained between
uncharged DMPC bilayers, as it cannot swim away without any excess
water [36,54]. In the present solid state NMR study, we therefore need
not be concerned about the initial binding equilibrium. Instead, weFig. 4. Inﬂuence of lipid headgroup charge on the re-alignment of PGLa (left), and GS (right),
measured in a DMPC matrix containing 10% anionic DMPG (A), 25% (B), and 50% (C). The
lipid phase transition is indicated by arrowheads.
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GS, and see how this equilibrium is affected by the presence of 10, 25
and 50% anionic lipid.
It has been previously demonstrated that 19F-labeled PGLa in orient-
ed samples of pure DMPC gives the same spectra, at identical P/L and
comparable temperature conditions, as in the presence of 25% and
50% DMPG [37,38]. It was thus concluded that the structural behavior
of PGLa is unaffected by the presence of anionic lipids. However, those
experiments were only carried out in ﬂuid liquid crystalline samples,
so we now performed a series of temperature scans with mixtures of
DMPC and DMPG. The 19F NMR spectra in Fig. 4 (to be compared with
those of pure DMPC in Figs. 2B/3B) show that at temperatures above
the Tm the behavior of both PGLa and GS is not affected by the presence
of DMPG (10% up to 50%). Below the lipid phase transition, however, a
rather different picture emerges, which varies for the two peptides.
While PGLa becomes re-aligned in the gel-phase of pure DMPC (upﬁeld
signals in Figs. 2B/3B), re-alignment is impaired in the presence of
DMPG,which instead seems to stabilize a surface-bound state (downﬁeld
signals in Fig. 4A/B/C). In the case of GS, on the other hand, the surface-
bound state prevails in the gel-phase of pure DMPC (near-isotropic posi-
tion in Figs. 2B/3B), but the presence of DMPG below the phase transition
temperature promotes the re-aligned state (downﬁeld intensity in
Fig. 4A/B/C). The latter effect is nicely seen in the different spectra
acquired in the lipid gel phase at−15 °C, where the downﬁeld signal
of GS at−70 ppm is absent in pure DMPC, but grows with increasing
DMPG content and eventually dominates the spectrum at 50% DMPG.
In another series of experiments, spectra were collected with mixtures
of anionic DMPS/DMPC (data not shown), and the qualitiative behavior
of the two peptides was similar to the data with DMPG/DMPC. We may
thus conclude that anionic lipids have no signiﬁcant effect on the re-
alignment of PGLa and GS in the ﬂuid liquid crystalline phase. However,
the two peptides exhibit different trends in the lipid gel phase, as it had
also been noted in pure DMPC.Fig. 5. Inﬂuence of cholesterol content on the re-alignment of PGLa (left) and GS (right),
measured in a DMPC matrix containing 10% CHOL (A), 25% (B), and 50% (C). The lipid
phase transition of pure DMPC is indicated by arrowheads. Note the extended ppm scale
for PGLa in panel C.3.5. Inﬂuence of cholesterol
The presence of cholesterol is a major characteristic that distin-
guishes animal cell membranes from those of bacteria. High cholesterol
content is supposed to be an important factor governing the selectivity
of AMPs against prokaryotes versus eukaryotes, by sealing the mem-
branes against peptide insertion [13–16,63]. We therefore examined
the alignment preferences of PGla and GS in DMPC bilayers containing
10, 25, and 50 mol% cholesterol (CHOL). Again, 31P NMR conﬁrmed
that the lipids were well oriented and in the lamellar phase (data not
shown). The representative 19F NMR spectra of PGLa in Fig. 5A show
that a low cholesterol content (10%) keeps the peptide aligned on the
membrane surface at temperatures above Tm. Below the DMPC phase
transition temperature, the well-resolved multicomponent spectra in-
dicate a co-existence of the surface-bound state (downﬁeld signals)
and the fully re-aligned state (upﬁeld signals). At higher cholesterol
contents (25%), the lipid phase transition is completely smeared out,
as expected, and all spectra show just a broad lineshape (Fig. 5B). This
develops into an extremely broad triplet pattern at 50% CHOL (Fig. 5C,
note the different ppm scale). It appears that PGLa does not bind to
these membranes in the usual S-/T-/I-states that were seen above and
described in the literature so far. The maximum static 19F splitting is
found in Fig. 5C, similar to a situation reported recently for an amphi-
philic β-stranded peptide [KIGAKI]3 [20,21]. We may thus speculate
that the PGLa helix could have become unfolded in the presence of
50% CHOL, and might lie immobilized on the membrane surface in an
extended conformation [64].
The behavior of GS ismore readily interpreted from the distinct NMR
lineshapes. Compared to pure DMPC, the re-aligned state is dramatically
stabilized by 10% CHOL (Fig. 5A). This membrane composition actually
seems to be most effective in promoting the immersed state of GS,
compared to all other lipid systems examined here. At higher cholester-
ol content (25%, 50%), on the other hand, static powder patterns are
observed for all temperatures in Fig. 5B/C. In these cholesterol-rich
mixtures, the peptide completely loses its orientation. This observation
suggests that GS is excluded from the lipid bilayer and/or cannot bind
any more in an ordered manner. At the same time 31P NMR indicates
that the phospholipids maintain their high-quality lamellar orientation
(data not shown).
3.6. Lipid mixtures mimicking bacterial membranes
Apart from the negative charge and the absence of cholesterol,
another distinct feature of bacterial membranes is a high content of
phosphatidylethanolamines (PE) and cardiolipins (CL). Both of these
lipids have a small headgroup and thereby promote negative bilayer
curvature [65,66]. Even though these lipids are also present in other
cell types, it is often assumed that a bacterialmembrane can bemodeled
as a PE/PGmixture [67]. To ﬁgure out how PGLa and GS respond to such
an environment, we collected temperature-dependent 19F NMR spectra
in a 1:1 POPE/DMPG2 mixture. Furthermore, oriented samples were
prepared also with a total lipid extract (TLE)3 from E. coli, which should
be closer to the native lipid composition than any synthetic mixture.
Fig. 6A/B shows that both PGLa and GS are retained in the surface-
bound state in these samples throughout all temperatures investigated.
Apparently, neither PGLa nor GS are able to re-align in these bacteria-
mimicking membranes. This observation supports a recent study
in which we had examined PGLa and GS in native biomembranes,
prepared fromMicrococcus luteus bacterial protoplasts and from human2 In the POPE/DMPG mixture the individual lipid phase transition temperatures are
close to one another (25° and 23 °C, respectively), such that homogeneous bilayers are
readily formed. In other acyl chain combinations, poor miscibility and lateral phase sepa-
ration are expected to severely perturb the homogeneity of the bilayer at ambient
temperatures.
3 The TLE contains approximately 4:1 PE/PGand10%CL, such that PE/(PG+CL) is about
7:3.
Fig. 6. Inﬂuence of bacterial membrane-mimicking lipids on the re-alignment of PGLa
(left) and GS (right), measured in a POPE/DMPG mixture (A), and in a total lipid extract
from E. coli (B).
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prints of the surface-bound states, and re-alignment was not detected
in bacterial membranes, but detected in erythrocyte ghosts.
4. Discussion
Formanyyears peptide–lipid interactionshave been amajor focus in
studies of antimicrobial peptides. Even though attention is starting to
shift towards other modes of intracellular action, involving DNA, RNA,
signaling or energy-generating systems, the plasma membrane is still
an obligatory interaction partner for AMPs. After all, any peptide will
need to break or translocate across this barrier, even if its main target
is in the cytosol [68,69]. Therefore, it is important to systematically
investigate the basic interactions between different AMPs and different
lipids. In this work we have compared the structural behavior of two
amphiphilic AMPswith fundamentally different primary and secondary
structures: the α-helical PGLa and the cyclic β-stranded gramicidin S,
bound to model membranes of varying composition and with different
properties (ﬂuid/gel phase, membrane thickness, surface charge, cho-
lesterol content, bilayer curvature). Despite their marked differences
in structure and charge, the two amphiphilic AMPs show surprisingly
similar re-alignment behaviors, which suggest very similar peptide–
lipid interactions as well as similar functional mechanisms towards
membrane disruption and/or pore formation. Both of them bind to
membranes in a surface-bound state, and can re-align and insert more
deeply into the bilayer with increasing concentration [27,37,38,46].
We used solid state 19F NMR tomonitor the alignment states of the pep-
tides by rapidly acquiring “ﬁngerprint” lineshapes. Experiments were
carried out to screen peptide concentration (Fig. 2A), temperature
(Fig. 2B), and various lipid environments (Figs. 3–6).
Methodologically, the present studymay be regarded a as a proof of
principle that a single 19F-reporter group on a peptide can be used for
fast and efﬁcient high-through put screen of many different conditions.
The spectra presented here do not display perfect lineshapes, and they
have not been optimized individually. Nevertheless, they are of sufﬁ-
cient quality to extract the essential information, namely whether the
peptide has re-aligned or not, or whether a powder spectrum or some-
thing unusual is seen (e.g. fast exchange). Within these caveats, we do
not attempt to analyze our data quantitatively, but the observed trends
are deﬁnite and can be reproduced. We typically used 0.5 mg peptide
and acquired each spectrum in less than 2 h, which ensures that the
sample stays well hydrated [41,53]. Solid state NMR experiments
based on conventional isotope labels (2H, 15N) would require larger
amounts of peptide (severalmilligrams) and longer (tens of hours)mea-
surement times. Besides the high cost, such long experimentswould alsoaffect the hydration state of an oriented sample, which would inevitably
dry out in a temperature series and would in turn shift the lipid phase
transition Tm to signiﬁcantly higher temperatures. This risk was mini-
mized by 19F NMR, and the sample integrity could be conﬁrmed by 31P
NMR afterwards.
When studied under conditions close to the threshold for re-
alignment, we found that both peptides immerse most favorably into
phosphatidylcholine membranes at temperatures around the respective
lipid phase transition. Inmodelmembranes consisting of a single synthet-
ic lipid type, the gel and ﬂuid liquid crystalline phases co-exist as discrete
domains at the phase transition temperature Tm [70–72]. Numerous lipid
packing defects are present at the domain boundaries, which should facil-
itate themembrane insertion of a peptide and hence a change in its align-
ment. This instability at Tm explains why the observed re-alignment of
PGLa and GS is coupled to the chain melting transition in synthetic lipid
bilayers.
When enriched with cholesterol the lipid phase transition disap-
pears, and cholesterol is considered to act as a membrane “sealer”.
Accordingly, we saw that ≥25% CHOL impairs the re-alignment of
PGLa, and prevents the binding of GS in a well-aligned state altogether
(Fig. 5). Remarkably, in the presence of 10% cholesterol we observed a
strikingly different behavior for both peptides. PGLa and GS did not
only bind strongly to these membranes, but their re-alignment was
actively promoted. In fact, the re-alignment of GS was most favorable
in the presence of 10% cholesterol in a DMPC matrix, compared to any
other lipid composition studied. It is conceivable that cholesterol
induces numerous bilayer defects or microdomains in this particular
concentration regime [73], where it starts to broaden the phase transi-
tion region that is per semost sensitive to peptide insertion.Membranes
with low cholesterol content might thus be particularly susceptible to
membrane-active peptides. This could include, e.g., cholesterol-poor
domains in the plasma membrane, but also ER/Golgi membranes,
which become accessible to endocytotically acquired cationic peptides.
In bacterial-mimicking lipid mixtures of POPE/DMPG and in E. coli
total lipid extract, as well as in native biomembranes [29,57], we did
not see any re-alignment of either peptide (Fig. 6). From a biological
point of view, this ﬁnding might be unexpected at ﬁrst sight, given
that AMPs have a high selectivity for bacterial cells [74]. However, our
observations are in good agreement with the physico-chemical proper-
ties of these lipid systems. Lipids with a high negative curvature have
been shown to prevent the immersion of the amphiphilic α-helical
peptide MSI-103, which closely resembles PGLa [44]. The present data
on PGLa and GS support this curvature concept, as bacterial lipids
typically have small headgroups (PE, CL) and bulky unsaturated acyl
chains. Such bilayers keep the peptides in the surface-bound state,
as– conceptionally – there ismuch room for themwithin theheadgroup
region. Indeed, direct dipolar interactions have been detected between
the PG headgroup and the interfacial arginine side chain of human
cathelicidin LL-37 and its fragments [75,76]. Lipidswith large headgroups
and short saturated chains, on the other hand, have a positive spontane-
ous curvature, which favors the re-alignment and deeper insertion of
peptides into the hydrophobic core [44]. Extending the curvature concept
further, we may even argue that increasing temperature leads to an
increasingly negative curvature of any lipid, as the ﬂuctuating acyls
chains will occupy a larger volume. Accordingly, in our present and
previous temperature serieswe always saw that if a peptide had properly
re-aligned in a stable state above Tm (e.g. at high P/L ratio), it would
eventually become surface-bound upon raising the temperature.
Regarding the properties of the lipid acyl chains, we have demon-
strated here that both PGLa and GS have the same tendency to re-
align favorable in thin DLPC bilayers, less so in DMPC, and not at all in
DPPC (when measured under equivalent conditions of appropriate
peptide concentrations and relative temperatures, Fig. 3). This series
can also be rationalized by the curvature concept, as the lipid curvature
decreases with increasing acyl chain volume from DLPC to DMPC to
DPPC. Cosequently, the threshold concentrations for re-alignment of
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DMPC (Fig. 2A), while the thresholds in DPPC must be even higher. It
would be interesting to verify these expected trends by providing actual
numbers. However, the experimental effort to measure such
concentration series is considerable, as individual samples would need
to be prepared for each spectrum. Instead of scanning peptide concentra-
tions, it is much more convenient to scan the temperature using one and
the same sample, which was the main approach taken in this study.
Different peptides obviously have different threshold concentrations
for re-alignment, as seen here for PGLa and GS in DMPC at 25 °C (Fig. 2A),
and these values will furthermore differ in each and every lipid system
studied. Nevertheless, the relative values are shifted by the speciﬁc
membrane environment in a consistent manner according to the bilayer
properties, such as lipid curvature and bilayer defects. With these two
exemplary peptides, examined under different conditions (concentration,
temperature) and in different types of lipids, we have demonstrated that
peptide–lipid interactions are based on fundamental physico-chemical
properties of the participating molecules. This particular importance of
lipids has been also discussed recently from perspective of the pore for-
mation mechanism [77]. When comparing the effect of different AMPs
on different types of cell membranes, it can thus be expected that the ac-
tual events at the level of the lipid bilayer proceed in a quantitatively pre-
dictable way. On the other hand, the observed biological activities of
different peptides against different strains do not necessarily correlate
with lipid composition. That is because the “effective” antimicrobial activ-
ity will obviously depend on the local concentration that can be achieved
for each individual peptide at the cell surface. This initial binding interac-
tion is largely governed by electrostatic attraction to lipids and other cell-
surface components, which was not considered here.
For instance, the present study has shown that re-alignment and
membrane immersion do not proceed readily in bacterial membranes
andmimicking lipidmixtures thereof. The presence of negatively charged
head groups has no favorable effect on promoting re-alignment per se
(Fig. 4), and the typical bacterial lipid PE even hinders peptide immersion
due its high negative spontaneous curvature (Fig. 6) [44]. The fact that
antimicrobial peptides are nevertheless particularly active against bacte-
rialmembranes compared to eukaryotic ones,must therefore be attribut-
ed purely to strong electrostatic attraction. In order to permeabilize a
bacterial cell, it is likely that much higher peptide concentrations are
needed than the P/L ratios at which re-alignment in model bilayers was
observed. From a quantitative point of view, it is important to note that
the peptide concentrations used here (P/L of 1:20 to 1:200) are far
below the corresponding MIC values. By considering the average surface
area (2 × 4 μm2) of all bacteria in an antimicrobial assay, it was estimated
that a typicalMIC of 8 μg/ml corresponds to a nominal P/L ratio N1:1 [78].
Compared to the concentrations that would be present, even if only a
fraction of the peptides binds to the membrane at a given time, we
have thus monitored sub-MIC effects here. The surprisingly unfavorable
tendency for PGLa and GS to undergo re-alignment in bacterial-mimick-
ing lipid mixtures thus has to be compensated in vivo by a high local
peptide concentration attracted electrostatically. On the other hand, the
number of pores needed to kill a bacterial cell does not need to be very
large [79], and only a small fraction of the membrane-bound molecules
may be involved in a transient event. In an NMR experiment, such a
small but sufﬁcient population of active, re-aligned structures may be
too low for observation under realistic conditions.
Overall, we have shown that the two amphiphilic peptides PGLa (α-
helical 21mer, charge +5) and gramicidin S (cyclic β-pleated decamer,
charge +2) resemble each other closely in their re-alignment behavior,
once their respective threshold concentrations formembrane immersion
is taken into account. Their functional mechanism therefore seems to be
determined in a very similar way by the physico-chemical parameters of
the lipid system. These observations suggest that it is not the peptide per
se, but rather the phase state and lipid composition of the target cell
membrane that inﬂuence the re-alignment and membrane insertion of
antimicrobial peptides.Acknowledgements
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